Departments

Department of General and Thoracic Surgery

Director:

  • Prof. Dr. med. Thomas Becker


The Department of General and Thoracic Surgery was founded in 1862 and covers the entire spectrum of abdominal and thoracic surgery using the most up-to-date surgical techniques. As it provides state-of-the-art care, its main focus areas are in the oncological treatment of gastrointestinal tumours, the surgical treatment of peritoneal carcinosis and bronchial carcinoma. Minimally invasive surgery, endocrine surgery and bariatric surgery are firmly established speciality areas. Transplant surgery (kidneys, pancreas, liver, small intestine) and liver tissue transplants from living donors in children and adults represent another area of focus.

Research is concentrated on oncology and transplantation medicine. Research is also conducted on the mechanisms at the origin of tumour conditions and intervention strategies. Research into the regeneration and tolerance induction of organ transplants is another focus area.

Department of Pediatric and Adolescent Medicine I

Director:

  • Prof. Dr. Martin Schrappe


The Department of Pediatric and Adolescent Medicine I has been in existence for around 100 years. It provides standard and maximum paediatric hospital care, and has an outpatient clinic for complex conditions. Its healthcare speciality areas are in specific haematology and oncology, bone marrow and organ transplantation, neonatology, endocrinology and diabetology, rheumatology, pulmology, allergology and infectiology in addition to gastroenterology, hepatology and nephrology.
In addition to the two intensive care wards and a paediatric surgery ward, there are three hospital wards, special outpatient departments and, since 2010, a haematological oncology day clinic.

Research is focused on translational and clinical issues. The Department is the co-ordination centre of the largest clinical trial for acute lymphoblastic leukaemia in children in Europe. Research is also being conducted currently in endocrinology, pulmonary inflammation and transplantation medicine.

Department of Anesthesiology and Surgical Intensive Care

Acting Director:

  • Prof. Dr. Markus Steinfath


In the Department of Anesthesiology and Surgical Intensive Care the most modern anaesthetic technology is used for approximately 24,000 anaesthetics administered annually. Surgical intensive care is delivered using all organ replacement procedures, ground-based and airborne emergency medicine in Kiel and the surrounding areas and outpatient and hospital pain medicine and palliative medicine with a 24 hour acute pain service are provided by the physicians in the Department.

The Department of Anesthesiology and Surgical Intensive Care is also very actively involved in scientific research. The focus is on the investigation of molecular mechanisms in anaesthetics, organ protection, resuscitation, monitoring and the development of innovative ventilation techniques and functional imaging of the lungs and sepsis.

The Department's primary teaching objective is to introduce the subject of anaesthetics to students, including all its important branches and to show the versatility of this subject. It is taught through lectures in the subject of anaesthesiology, overlapping areas with emergency medicine, health economics, infection biology and ethics and the optional subjects of pain treatment, palliative medicine and the neuromuscular system. In addition, the Department participates in an interdisciplinary examination course and offers simulation training with the use of medical treatment procedures in complex cases.


Department of Congenital Heart Disease and Paediatric Cardiology

Director:

  • Prof. Dr. Hans-Heiner Kramer


The Department of Congenital Heart Disease and Paediatric Cardiology is one of the oldest German clinics for the treatment of patients with congenital heart conditions, from neonates to adults. The Department is in the top 5 international centres for the treatment of the most severe congenital heart condition, hypo plastic left heart syndrome.

Research activities at the Department are involved in prospective studies that focus on this unique type of patient group. In 2009, a collaborative study of molecular genetics was begun with the Max Delbrück Center for Molecular Medicine in Berlin. Due to the severe implications of a dysfunction in the right ventricle in different heart conditions and the urgent need for early detection of its impact on the intrinsic ventricular function, diagnostic techniques are used on studies of diverse congenital heart diseases.  An animal laboratory is used in cooperation with cardiac surgery to investigate and define intervention techniques for congenital heart diseases.

Department of Applied Cell Therapy

Director:

  • Prof. Dr. Fred Fändrich


The Department of Applied Cell Therapy is involved in the development of new, individualised forms of treatments for use in the future. Its three main medical areas of application are: (i) immunotherapy of autoimmune diseases (ii) the use of autologous cellular products for the regeneration of degenerative tissue and vessels and (iii) the immunotherapy of malignant tumours.

The cellular products are derived from autologous monocyte cells, which are reinjected into the patient, after cellular programming in the GMP laboratory. This form of personalised - patient centred - treatment aims to treat the cause both preventively and causally. Diseases characterised by chronic inflammation are a particular area of focus for future treatment concepts.

These innovative approaches are needed in response to the demographic evolution of western industrialised nations, with significantly longer life expectancies and decreasing birth rates. This is leading to greater cost pressures in the health system, which is generating more demand for preventive and causal treatment strategies.

The Faculty of Medicine and the UKSH have responded to this development by setting up the Department of Applied Cell Therapy. Pre-clinical and initial clinical research findings of this translational application research are used to develop innovative cell-based forms of treatment for the future, in collaboration with other specialist clinics and industrial partners. The objective is that patients will be able to benefit from this research in the future.

Department of Dermatology, Venerology and Allergology

Director:

  • Prof. Dr.med. Thomas Schwarz


The Department of Dermatology, Venerology and Allergology was founded in 1902. It covers both the diagnosis and treatment of the entire spectrum of dermatology, venerology and allergology.

The Department has one of the largest centres for clinical trials in Germany. Its research focuses on the investigation of chronic inflammatory skin conditions and dermatooncology. In addition to clinical and epidemiological research on psoriasis, neurodermitis and melanoma, research is also conducted primarily in the clinical research group "Mechanismen kutaner Entzündungsreaktionen" (mechanisms of cutaneous inflammatory reactions). The effects of ultraviolet radiation on the skin are also analysed.

The Department of Dermatology, Venerology and Allergology has received the Faculty of Medicine's Teaching Prize on numerous occasions for excellence in teaching the subject of Dermatology. This is awarded on the basis of student evaluations.

Department of Gynaecology and Obstetrics

Director:

  • Prof. Dr. med. Nicolai Maass


The rich traditional and scientific success story of the Department of Gynaecology and Obstetrics begins with the opening of the first birthing house in Kiel in 1805. Personalities such as Michaelis, Pfannenstiel and Litzmann have taught here in the past 200 years. The Department is still one of the largest gynaecological hospitals in Germany today.

In its early days, Kiel's University Hospital for Women made a significant contribution to the development of modern medicine. Under the direction of Kurt Semm, minimally invasive surgery began in Kiel and became an integral part of surgical treatments throughout the world. The Department ensures the highest level of medical care in gynaecology and obstetrics, by continuing this tradition in Kiel's School of Gynaecological Endoscopy and based on the top quality of its Obstetrics Medicine (Perinatal Centre Level I) combined with its focus on the diagnostics and treatment of breast cancer and gynaecological tumours.

A large-scale scientific working group is tackling current issues in obstetrics and prenatal diagnostics and also the biggest genetic and treatment challenges in adjuvant and metastasised tumour treatment.

The Ear, Nose and Throat Department

Director:

  • Prof. Dr. med. Petra Ambrosch


The Ear, Nose and Throat Department (ENT) is a maximum medical care unit specialising in oncology, rhinology, otology (including interventions with implanted hearing aids and cochlear implants) and plastic reconstructive head and neck surgery. Its expertise in the field of transoral laser microsurgery of malignant tumours of the upper respiratory and digestive tracts is respected and in demand worldwide.

The Department is a member of the Krebszentrums Nord/Comprehensive Cancer Center (CCC) located at the UKSH. The CCC is run jointly by the Faculties of Medicine at the universities of Kiel and Lübeck. Oncological patients of the Department are cared for in a DKG-certified head and neck tumour centre.

The main research specialities of the ENT are in the field of carcinogenesis associated with the human papillomavirus in head and neck cancers, the investigation of oncological and functional outcomes following transoral laser microsurgery, the investigation of surface lesions on the respiratory epithelium in granulomatosis with polyangitis and other ANCA associated vasculitis, as well as the optimisation of speech processor adjustments in cochlear implants.

Department of Cardiac and Vascular Surgery

Director:

  • Prof. Dr. med. Jochen Cremer


The Department of Cardiac and Vascular Surgery was founded in 1974 with a professorship in Kiel. Prof. Cremer has been the Director since 1998. The Department offers the entire spectrum of adult cardiac surgery and vascular surgery as well as complete surgical treatment of congenital heart diseases. Coronary surgery is a focal area. Full arterial revascularisation and minimally invasive direct coronary artery bypass (MIDCAB) (without the need for a heart lung machine) deserve special mention. The programme is completed by conventional or minimally invasive procedures for valve replacement and valve reconstruction.

The thoracic transplant programme was started in 1986, in the Department of Cardiac and Vascular Surgery, with the first heart transplant. Since then it has had an active transplant programme for thoracic organs (heart, lung, heart and lungs) using mechanical cardiovascular support procedures. The Department's experimental research focus is in the field of innovative concepts in endocardial valve surgery in conjunction with tissue engineering of the aortic valve and stent-based mitral valve implants.

It collaborates on an interdisciplinary level with international research groups. A further research focus is currently emerging from clinical care strategies in acute myocardial infarction involving experimental investigations and pharmacological studies.

In addition to curriculum teaching to medical students, the Department of Cardiac and Vascular Surgery also offers complete advanced training to Consultant level in cardiac surgery and to Consultant level in vascular surgery as well as the two year advanced training for internal medicine with the option to graduate Basischirurgie as part of Common Trunk (BDC - basic surgical training). Student Shadowing and Clinical Placements can be arranged by consultation. Elective seminars on current topics are organised on a subject-related basis.

Department of Internal Medicine I - Gastroenterology, Hepatology, Pulmonology, Internal Intensive Care, Endocrinology, Infectious Disease, Rheumatology, Nutrition and Geriatric Medicine

Director:

  • Prof. Dr. med. Stefan Schreiber


The Department of Internal Medicine I  is one of the largest internal medicine departments in Schleswig-Holstein and offers a broad mix of designated focus areas. With gastroenterology, hepatology and pneumology, clinical infectiology and endocrinology/diabetology, nutritional medicine and geriatric medicine, in addition to internal acute and intensive medical care, it makes a broad contribution to general internal maximum care at the UKSH, Campus Kiel.

The Department collaborates with the other UKSH departments, in particular with the other three departments of internal medicine. Resident physicians in special outpatient clinics can also consult the rest of the team when assessing special cases.

Research focus is in the field of Inflammation Medicine and Geriatric Medicine. By transferring the research results from fundamental research to interdisciplinary medical care, the department is dealing with future challenges in medicine. The Department of Internal Medicine I has a leading role in the Cluster of Excellence 'Inflammation at Interfaces'.

The Department offers clinical introductory courses, examination courses and basic and specialist lectures to students of Medicine. It also provides training during the practical year and Consultant training.

Department of Internal Medicine II - Haematology, Oncology

Director:

  • Prof. Dr. med. Dr. rer. nat. Michael Kneba


The Department of Medicine II, specialising in haematology and oncology, and with two locations on the UKSH's Campus Kiel and in the Städtisches Krankenhaus Kiel (community hospital Kiel), is the largest haematology oncology maximum care hospital in Schleswig-Holstein. It offers all treatment procedures including autologous and allogeneic blood stem cell transplants. An interdisciplinary oncological outpatient department is located on the UKSH's Campus Kiel, which is operated jointly with the Department of General and Thoracic Surgery. There is also an inpatient department. The Department is also home to the Dr. Mildred-Scheel-Haus, the centre for bone marrow and stem cell transplantation and cellular immunotherapy. The Division of Stem Cell Transplantation and Immunotherapy is also part of the Department of Medicine II.

The medical focus is on the diagnostics and treatment of malignant organ tumours and conditions of the haematopoietic system, blood clotting disorders and infectious diseases (speciality in HIV medicine). Patients with haematological and oncological diseases are treated promptly and comprehensively in interdisciplinary tumour outpatient clinics at both locations. The special outpatient department operates as a central starting point for all of Schleswig-Holstein.

The Department is part of the Krebszentrums Nord/Comprehensive Cancer Center. It also works closely with the UKSH tumour centre, which supports both hospital and outpatient care. This means that medical and psychosocial support can be integrated at an early stage in the patient's care.

Division of Stem Cell Transplantation and Immunotherapy

Head of the Division:

  • Prof. Dr. med. Martin Gramatzki


The Division of Stem Cell Transplantation and Immunotherapy is located in the Dr. Mildred-Scheel-Haus. The building is equipped with modern clean rooms and internal and paediatric haematologists work here in close interdisciplinary co-operation, to provide over 100 patients annually with haematopoietic stem cell transplants.

The division is a member of the European Group for Blood and Marrow Transplantation (EBMT) and is accredited according to the international criteria of the JACIE (Joint accreditation committee ISCT and EBMT). In addition to stem cell transplantation, a competence centre for targeted treatment procedures (monoclonal anti-bodies, immune cells and "small molecules") has also been set up here.  Wards, outpatient departments, cell apheresis units and a Good Manufacturing Practice (GMP) laboratory for the production of innovative marketable drugs and translational research are inextricably linked.

The scientific work is based on international co-operation and support from significant research sponsors such as the DFG (German Research Foundation), Deutsche Krebshilfe (German Cancer Aid), and the José Carreras-Stiftung and W. Sander-Stiftung. Research and clinical work has a special focus on the pathophysiology and treatment of plasma cell tumours. The division is fully integrated into the university teaching.

Department of Internal Medicine III - Cardiology and Angiology

Director:

  • Prof. Dr. med. Norbert Frey


The Department of Internal Medicine III, specialising in cardiology and angiology, is a maximum care centre that offers a broad range of clinical care to patients with cardiovascular conditions. In addition to the treatment of coronary heart diseases, it also specialises in the treatment of myocardial weaknesses, myocardial diseases and cardiac arrhythmias. Minimally invasive cardiac valve treatment is a particular speciality.

Research focuses on understanding the molecular causes of myocardial diseases and cardiac insufficiency. As part of the National Genome Research Network the department collaborates with many leading national and international institutions. In addition to these research activities, many clinical studies are also conducted in the area of acute coronary syndrome, cardiac arrhythmias and cardiac insufficiency.

The Department of Internal Medicine III is a unit of the DZHK - German Centre for Cardiovascular Research, together with the Universität Hamburg and the Universität zu Lübeck. This BMBF-supported initiative of the Deutsche Zentren für Gesundheitsforschung (German Centres for Health Research) represents a pioneering reinforcement of translational cardiovascular research in Kiel.

Department of Internal Medicine IV - Nephrology and Hypertension

Director:

  • Prof. Dr. Ulrich Kunzendorf


The Department of Internal Medicine IV is the only independent Department of Nephrology in Schleswig-Holstein. The Department's focus is on the detection, prevention and treatment of nephrological and hypertension disorders. The Department has special expertise in the field of kidney and kidney-pancreas transplant and in the treatment of autoimmune diseases that affect the kidneys. The Department offers the entire spectrum of diagnostic and treatment procedures in modern nephrology.

In addition to medical care, the Department also conducts intensive experimental and clinical research in the field of nephro-immunology. The Department is actively engaged in training medical students.

Department of Child and Adolescent Psychiatry and Psychotherapy

Director:

  • Prof. Dr. Dr. Lioba Baving


The Department of Child and Adolescent Psychiatry and Psychotherapy in the Zentrum für Integrative Psychiatrie (ZIP - Centre for Integrative Psychiatry) is responsible for all paediatric and adolescent psychiatric health care in Kiel. Treatment is delivered via 40 inpatient clinics and 15 day clinics, a psychiatric outpatient institute, as well as a special outpatient department for attention deficit/hyperactivity disorder.

Research focuses on the experimental investigation of memory processes as well as emotional, reward and olfactory perception in child and adolescent psychiatric patients. The research into our primarily psychophysiological studies (EEG, fMRT) focuses on children and adolescents with attention deficit / hyperactivity disorder (ADHD), in particular.

The research activities are supported by the Collaborative Research Centre 'Plasticity and Sleep' (CRC (SFB) 654; 2005-2017). The department has its own research laboratory and is linked with numerous institutes at Kiel University and other national and international universities.

Department of Neurosurgery

Director:

  • Prof. Dr. med. Michael Synowitz


The Department of Neurosurgery in the Neurozentrum (Neuro Centre) at the UKSH, Campus Kiel is the largest neurosurgical department in Schleswig-Holstein. The range of treatments covers the entire field of surgically treatable conditions of the nervous system. It is uniquely characterised by the integration of a high-field MRT in the surgical department for intraoperative quality control. Its main focus areas in research and patient care are brain tumours, cerebrovascular disorders and movement disorders.

Furthermore, the Department participates in national and international studies, partially with leading roles, on brain tumours, conditions of the cerebrovascular system, of the spinal cord and movement disorders. It also co-operates with the Department of Neurology in the field of movement disorders, with the Department of Neuroradiology for projects on cerebrovascular conditions and with the Department of Trauma Surgery for studies on conditions of the spinal cord and skull base surgery.

Department of Neurology

Director:

  • Prof. Dr. Daniela Berg


The Department of Neurology works closely with the Department of Neurosurgery and the Department of Neuroradiology in the Neurozentrum (Neuro Centre) Kiel. It is equipped with the latest treatment and diagnostic facilities for all neurological conditions and has an intensive care unit, a stroke unit and an epilepsy monitoring unit. The Section for Neurological Ache Research and Therapy is part of the Department of Neurology.
Research and treatment focus on Parkinson's Disease, movement disorders, pain disorders, stroke-related conditions and epilepsies.

The Department has numerous research laboratories and a centre of studies. All clinical research focal points offer special outpatient clinics. The Department is involved in numerous national and international research associations.

Section for Neurological Ache Research and Therapy

Head of the Section:

  • Prof. Dr. med. Ralf Baron


The Section for Neurological Ache Research and Therapy was founded in 2004 and is linked with the Department of Neurology. Scientific research focuses on the investigation of pathophysiological mechanisms that cause pain to occur and to become chronic and the treatment of different neuropathological pain syndromes. Employees in the Section have already performed numerous studies on chronic pain.

The Sectional Director, Professor Baron, is a speaker of the German Research Network on Neuropathic Pain (DFNS e.V.). The purpose of this network of German pain researchers is to obtain a better understanding of the pathophysiological mechanisms involved in the development of neuropathic pain and the use of early intervention to prevent pain from becoming chronic.

Department of Pediatric and Adolescent Medicine II

Director:

  • Prof. Dr. Ulrich Stephani


The Department of Pediatric and Adolescent Medicine II is part of the Universitätskinderklinik zu Kiel (Department of Pediatric and Adolescent Medicine I) founded in 1906, and has operated as an independent department since 1974. It is the only independent paediatric neurological university department in a large radius of over 300 km. The Department is equipped with the latest treatment and diagnostic facilities for all neurological conditions in children and adolescents.

A special feature in the health care and research here is a "public private partnership" led cooperation with the Northern German Epilepsy Centre for Children and Adolescents.

The research focus in the Department of Pediatric and Adolescent Medicine II is on genetics and the functional imaging of epilepsies. Doctors and scientists in the Department collaborate with many working groups in Europe, the USA and Australia.

Department of Nuclear Medicine

Acting Director:

  • Dr. med. Ulf Lützen


The Department of Nuclear Medicine was set up as an independent department with a professorship in 1991. It is a maximum care hospital located in the Karl-Lennert Comprehensive Cancer Center and integrated with the UKSH Onkologisches Zentrum (Oncology Centre).

The Department is equipped with the latest camera systems including hybrid devices for nuclear medical diagnostics and treatment using open radioactive materials and radio-pharmaceuticals. The Department also has its own radio chemistry/pharmacy fitted with fully modern equipment, and a GMP area. It thereby offers the entire spectrum of nuclear medicine diagnostics and treatment.
 
In the Krebszentrum Nord/Comprehensive Cancer Center, the Department of Nuclear Medicine has a treatment ward with eight beds and two other interdisciplinary beds. The main indication for treatment with open radioactive materials is benign and malignant thyroid disorders. The main focus in outpatient care is thyroid diagnostics taking functional imaging into consideration using scintigraphy and morphological anatomical imaging using the latest ultrasound diagnostics. An MRT device is also available.
 
The subject of Nuclear Medicine with the other disciplines in radiology (radiation therapy / radio-oncology and diagnostic radiology including neuro-radiology) are integrated into student teaching. In addition to curricular lectures in the eighth semester, students complete a practical in the ninth semester. Lecturers also offer supplementary lectures and practicals for students on a voluntary basis.
 
Research is focused on the development and improvement of new and existing radio pharmaceuticals and radio tracers. Scientists also develop computer-aided evaluation programs for morphological and functional imaging. Other research interests are the treatment of thyroid disorders using radioactive materials and work in the field of radiation protection. The Department of Nuclear Medicine supports a large number of regional, national and international clinical trials.

Department of Ophthalmology

Director:

  • Prof. Dr. Johann Roider


The Department of Ophthalmology in Kiel was founded in 1888 and today it is equipped with the most modern facilities for the diagnosis and treatment of all eye-related issues. The Department is a maximum medical care facility. It treats cataracts and also places special emphasis on the diagnostics and treatment on conditions of the retina, vitreous body and the cornea, inflammations, tumours and glaucoma and eye muscle weaknesses.

Research is focused on conditions of the posterior segment of the eye, especially treatment of the age-related macular degeneration and conditions of the vitreo-retinal interfaces. The Department has set up a basic research laboratory, an ophthalmopathological laboratory and a cornea bank. The Department has been involved in numerous national and international treatment studies for several years.

Department of Orhtopedics and Trauma Surgery

Director:

  • Prof. Dr. med. Andreas Seekamp


The Department of Trauma Surgery (Traumatology) specialises in the care of trauma injuries and their secondary complications and conditions. This includes in particular, the treatment of patients who are severely injured or who have multiple injuries and the treatment of severe individual injuries of the pelvis, spinal cord and the extremities. Patients are treated with the latest surgical endoscopic methods as well as minimally invasive and computer-aided surgical procedures.

The Department's main research areas are tissue regeneration of cartilage, bone and soft tissue, and also "Trauma - another type of inflammation reaction".

The Department's teaching activities are related to injuries of the musculoskeletal system and body cavities and their principles of treatment. Subjects are taught with support from an E-Learning platform.

Section for Oncology and Rheumatology Orthopedics

Head of the Section:

  • Prof. Dr. L. Gerdesmeyer

 

Section for hand, plastic and microsurgery

Head of the Section:

  • Prof. Dr. med. Andreas Seekamp

 

Department of Psychiatry and Psychotherapy

Acting Director:

  • Prof. Dr. med. Fritz Hohagen


The Department of Psychiatry and Psychotherapy has been part of the Zentrum für Integrative Psychiatrie (ZIP, Centre for Integrative Psychiatry), since 2004,  a subsidiary of the UKSH. Clinical healthcare patients are provided with the full range of diagnostic and treatment facilities available in modern psychiatry, based on a principle of disorder-specific, evidence based practice within inpatient, day ward and outpatient settings.

The following disorders are specifically treated here: depression, anxiety, bipolar disorder, schizophrenia, post-traumatic stress disorder, borderline personality disorder, somatoform disorder, cognitive disorders and dementia, internal and neuro-psychiatric sleep disorders, addiction and dependency. Consultative care of patients at the UKSH with co-morbidities is an important aspect of the work of the treating physicians.

A clinical and animal experiment sleep laboratory is used to investigate the research areas of sleep and neuroplasticity. Supported by the CRC 654, scientists examine the connection between sleep and memory. Other areas of interest are the neurobiological aspects of stem cell research and psychotherapy research, in particular in the field of post-traumatic stress disorders.

It co-operates nationally as part of the CRC 654 with the universities of Lübeck und Tübingen and the Max Planck Institute of Experimental Medicine in Göttingen and the Institute of Clinical Psychology at the University of Konstanz. Internationally it has links with the Scripps Clinic & Research Foundation in the field of induced pluripotent stem cells.

Department of Psychosomatics and Psychotherapy

Director:

  • Prof. Dr. med. Fritz Hohagen


The Department of Psychiatry and Psychotherapy is part of the Zentrum für Integrative Psychiatrie (ZIP, Centre for Integrative Psychiatry), a subsidiary of the UKSH.

It specialises in the treatment of people with personality disorders, who are mainly living with mental illnesses such as post-traumatic stress disorders, depressions, eating disorders or somatoform disorders.

Department of Radiology and Neuroradiology

Director:

  • Prof. Dr. med. Olav Jansen


The Department of Radiology and Neuroradiology developed from the former Department of Diagnostic Radiology and Neuroradiology. The latest imaging equipment and methods are available at the Department, including ionising radiation, nuclear resonance and ultrasound, and all types of imaging controlled interventions are performed here.

The main areas of research are interventional radiology, or image controlled invasive diagnostic and intervention measures, cardiovascular diagnostics using DSA, US, CT and MRT, 3 and 4D procedures in CT and MRT and morphological and functional diagnostics of the lung (volumetry, perfusion, ventilation). Apart from that, the scientists are involved in the quantification of image information (volumetry), image processing (e.g bone structure analysis as part of research into osteoporosis, molecular imaging in the MOIN CC) and different aspects of experimental radiology (e.g. thorax phantom, intimal hyperplasia, tumour volumetry, construction of an ultrasound device, development of a puncture system, etc.).

The Department has its own working group of research scientists. Staff at the Department are involved in intensive national and international collaborations.

Department of Radiotherapy

Director:

  • Prof. Jürgen Dunst


The Department of Radiotherapy is the largest radiation therapy facility in Northern Germany and is one of the most renowned radiation departments in Germany (Focus Clinic Rankings 2013).

Doctors at the Department offer the entire spectrum of inpatient and outpatient radiation intervention, including medicinal tumour treatment.

The Department of Radiotherapy trains students, doctors and also specialist medical personnel. Scientists at the Department are involved in researching new cancer treatment options.

Department of Urology

Director:

  • Prof. Dr. Klaus-Peter Jünemann


The range of services of the Department of Urology covers the entire spectrum of diagnostics and treatment of urological conditions in adults and children, including uro-oncological chemotherapy. Uro-oncology represents an important treatment speciality, whereby the extended lymph node surgery is particularly important in advanced stages of prostate, bladder and penile carcinomas.

Physicians in the Department have proven expertise in the field of what is referred to as salvage operations in PSA recurrence or recurrence of bladder carcinoma and are one of the leading departments in the field of sentinel lymphadenectomy. The 'Kiel Concept' was developed for the rehabilitation of erectile function following radical prostatectomy. It trains erectile function using PDE 5 inhibitors (Viagra®) and has been used successfully for many years.

The da Vinci®  Si Surgical System is used for sparing removal of the prostate and for surgery on the bladder and kidneys. This robot-assisted surgical system is currently the latest development in the field of minimally invasive surgery in the world. The University Medical Center Schleswig-Holstein is the only European clinic which, at the start of 2013, launched the da Vinci surgical system simultaneously in three core areas - urology, gynaecology and surgery.

The Kiel Department of Urology has been certified by the Deutsche Krebsgesellschaft (German Cancer Association) as a Centre for Prostate Cancer and is partnered with the Onkologisches Zentrum (Oncology Centre) on the Kiel campus. Interdisciplinary work ensures that each patient benefits from the expertise of all cancer care disciplines.

The Department is also a certified Centre for Continence and Pelvic Floor of the Deutsche Kontinenz Gesellschaft  (German Continence Association) with special expertise in the field of incontinence diagnostics and treatment in male, female and child patients.

The Department is actively involved in numerous national and international clinical studies and research projects and operates its own neuro-urological research laboratory.